COR – Cencora Inc
COR — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.45
Margin Of Safety %
6
Put/Call OI Ratio
0.69
EPS Next Q Diff
0.22
EPS Last/This Y
9.6
EPS This/Next Y
2
Price
350.05
Target Price
414.15
Analyst Recom
1.65
Performance Q
2.72
Upside
-47.8%
Beta
0.66
Ticker: COR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | COR | 361.75 | 0.71 | 3.05 | 16362 |
| 2026-03-10 | COR | 352.22 | 0.72 | 0.07 | 16386 |
| 2026-03-11 | COR | 350.22 | 0.70 | 1.08 | 16695 |
| 2026-03-12 | COR | 352.59 | 0.69 | 1.16 | 16723 |
| 2026-03-13 | COR | 352.65 | 0.69 | 1.20 | 16723 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-18 | COR | 360.05 | 9.7 | 1277.0 | 17.62 |
| 2026-02-19 | COR | 358.99 | 9.7 | 1262.7 | 17.62 |
| 2026-02-20 | COR | 361.16 | 9.7 | - | 17.62 |
| 2026-02-24 | COR | 364.45 | 7.5 | - | 17.62 |
| 2026-02-25 | COR | 363.02 | 7.5 | - | 17.62 |
| 2026-02-26 | COR | 366.65 | 7.5 | 1614.3 | 17.62 |
| 2026-02-27 | COR | 372.08 | 7.5 | 1676.7 | 17.62 |
| 2026-03-02 | COR | 372.65 | 7.5 | 1281.5 | 17.62 |
| 2026-03-03 | COR | 371.45 | 7.5 | 1263.5 | 17.62 |
| 2026-03-04 | COR | 368.27 | 7.5 | 1242.9 | 17.62 |
| 2026-03-05 | COR | 359.40 | 7.5 | 1183.1 | 17.62 |
| 2026-03-06 | COR | 358.39 | 7.5 | 1265.2 | 17.62 |
| 2026-03-09 | COR | 361.79 | 7.5 | 1312.2 | 17.62 |
| 2026-03-10 | COR | 352.39 | 7.5 | 1174.9 | 17.62 |
| 2026-03-11 | COR | 350.32 | 7.5 | 1255.5 | 17.62 |
| 2026-03-12 | COR | 352.76 | 7.5 | 1303.4 | 17.62 |
| 2026-03-13 | COR | 350.05 | 7.5 | 1247.4 | 17.62 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-06 | COR | -8.57 | 1.03 | 2.77 |
| 2026-03-09 | COR | -8.56 | 1.02 | 2.77 |
| 2026-03-10 | COR | -8.56 | 1.02 | 2.77 |
| 2026-03-11 | COR | -8.56 | 1.02 | 2.45 |
| 2026-03-12 | COR | -8.56 | 1.02 | 2.45 |
| 2026-03-13 | COR | -8.56 | 1.02 | 2.45 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
4.08
Avg. EPS Est. Current Quarter
4.75
Avg. EPS Est. Next Quarter
4.3
Insider Transactions
-8.56
Institutional Transactions
1.02
Beta
0.66
Average Sales Estimate Current Quarter
81369
Average Sales Estimate Next Quarter
87356
Fair Value
371.39
Quality Score
69
Growth Score
80
Sentiment Score
78
Actual DrawDown %
7.3
Max Drawdown 5-Year %
-17.8
Target Price
414.15
P/E
42.1
Forward P/E
17.88
PEG
1.66
P/S
0.21
P/B
35.68
P/Free Cash Flow
18.88
EPS
8.31
Average EPS Est. Cur. Y
17.62
EPS Next Y. (Est.)
19.62
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
0.5
Relative Volume
0.86
Return on Equity vs Sector %
57.3
Return on Equity vs Industry %
-277.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
1247.4
Cencora, Inc.Sector: Healthcare
Industry: Medical Distribution
Employees: 47000
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
COR
Latest News
—
Caricamento notizie per COR…
stock quote shares COR – Cencora Inc Stock Price stock today
news today COR – Cencora Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch COR – Cencora Inc yahoo finance google finance
stock history COR – Cencora Inc invest stock market
stock prices COR premarket after hours
ticker COR fair value insiders trading